Dhanwantaram Kashayam in classical Ayurveda

What it is

Dhanwantaram Kashayam (also spelled Dhanwantharam / Dhanvantaram Kashayam) is a classical Ayurvedic polyherbal decoction attributed to the Ashtanga Hridayam lineage, "consists of 40 herbal ingredients" and is taken as a water decoction (Renganathan & Pillai, J Diabetes Metab Disord 2020) (PMID 33553031).

Its traditional ingredient list comprises roughly 40 substances in equal parts: Bala root (Sida cordifolia), barley (Yava), horse gram (Kulattha), the ten Dashamoola roots (Bilva, Agnimantha, Shyonaka, Kashmarya, Patala, Shalaparni, Prishnaparni, Brihati, Kantakari, Gokshura), plus about three dozen further herbs, including Manjishta, Ashwagandha, Shatavari, Triphala fruits, Sariva, Kushta, Punarnava and Ela, along with rock salt (classical Ayurvedic reference aggregator, Tier 3). Commercial compositions and regional variants may differ, so labels should always be checked.

Note: Dhanwantaram Kashayam (the oral decoction described here) is a different product from Dhanwantaram Taila (the medicated oil used externally): the two are frequently confused and are not interchangeable.

Classical properties

• Taste (rasa): bitter (Tikta), astringent (Kashaya)
• Qualities (guna): light (Laghu)
• Potency (virya): warming (Ushna)
• After digestion (vipaka): pungent (Katu)
• Doshas: traditionally said to settle Vata; may increase Pitta

Traditional use

In classical Ayurvedic practice, Dhanwantaram Kashayam belongs to the care of Vata and of mothers after childbirth: it is indicated for vata diseases, including low back ache, arthritis-like joint pain, numbness and swelling, as well as for post-natal care, gynaecological conditions, and general weakness. The modern research paper notes its traditional use "as a growth stimulant in children and for nerve regeneration" (PMC 7843830; classical aggregator, Tier 3). These are traditional indications, not evidence of efficacy.

What research has looked at

Antidiabetic and antioxidant effects in diabetic rats, 2020

The strongest published study is a 2020 animal trial: 48 male Wistar rats with streptozotocin-induced diabetes received Dhanwantharam Kashayam at three dose levels for 21 days. Treated rats showed a dose-dependent fall in fasting blood glucose (17%, 54% and 76% reductions respectively), increased antioxidant markers (vitamins C and E, reduced glutathione) and reduced oxidative-stress markers (malondialdehyde, glycosylated haemoglobin, HOMA-IR) versus untreated diabetic rats (Renganathan & Pillai, J Diabetes Metab Disord 2020) (animal study, PMID 33553031). This is a rat finding: it is not evidence that the decoction treats diabetes in humans.

Stem-cell proliferation in the laboratory

An in-vitro study reported that a synthetic formulation of Dhanwantharam Kashaya enhanced proliferation and viability of Wharton's-jelly mesenchymal stem cells while retaining the stemness markers CD73 and CD90, without affecting non-stem control cells (Reghu et al., PMC 2019) (laboratory study). This is a cell-culture finding; it does not prove nerve regeneration or tissue repair in patients.

Phytochemical profile

A phytochemical analysis reported high phenolic, flavonoid and tannin content in the decoction with in-vitro antioxidant activity (DPPH and related assays), consistent with its multi-herb composition (Nandakumar et al., pharmacognosy study) (laboratory study).

Bottom line: the evidence is preclinical: animal and cell-culture studies suggest antioxidant and metabolic effects, but no human clinical trials of Dhanwantaram Kashayam exist, so its efficacy for back pain, arthritis, postnatal recovery or diabetes in people is unproven.

Safety notes

• Herbal-only formulation. Dhanwantaram Kashayam contains no metals or minerals: only herbs and rock salt. However, no human safety trials exist; the available safety-relevant data come from short-term animal dosing.
• During pregnancy and the postnatal period: the formula is traditionally used in postnatal care, but there are no controlled human safety data for pregnancy, breastfeeding or the postnatal period. It belongs only under the supervision of a qualified practitioner, especially after childbirth or when nursing.
• Children: traditional sources describe use in children as a growth stimulant, but no pediatric trial data exist; practitioner supervision is essential.
• With diabetes medicines: the rat study does not justify using the decoction for diabetes, and diabetes medicines are adjusted only with medical guidance.
• Interactions: none established; tell your healthcare provider about all Ayurvedic products you use, as NCCIH advises (NCCIH: Ayurvedic Medicine In Depth).
• Not interchangeable with Dhanwantaram Taila (oil): the external oil and the oral decoction are different products with different uses.

FAQs

What is Dhanwantaram Kashayam made of?

About 40 ingredients in equal parts, including Bala root, barley, horse gram, the ten Dashamoola roots, Manjishta, Ashwagandha, Shatavari, Triphala fruits, Sariva, Kushta, Punarnava, cardamom and rock salt. Commercial compositions may vary by manufacturer (classical aggregator, Tier 3).

What is it traditionally used for?

Classical sources indicate it for Vata disorders, low back ache, arthritis-like joint pain, numbness and swelling, as well as post-natal care of the mother and gynaecological conditions. These are traditional indications, not clinically proven effects (PMC 7843830).

Does research show it helps back pain or arthritis?

No human trials exist. A rat study of the decoction in diabetic rats showed antioxidant and blood-sugar effects, and a cell study showed stem-cell proliferation: neither tests back pain or arthritis in people. Efficacy is unproven (PMC 7843830).

What did the diabetes rat study find?

In 48 diabetic rats treated for 21 days, the decoction lowered fasting blood glucose dose-dependently (up to 76% at the highest dose) and improved antioxidant markers. This is an animal finding and is not evidence the decoction treats human diabetes (Renganathan & Pillai 2020).

Is it safe to use after childbirth?

It is traditionally used in postnatal care, but no controlled human safety data exist for the postnatal or breastfeeding period. Given the complex ~40-ingredient formula, use only under the supervision of a qualified practitioner: never self-medicate after childbirth (NCCIH).

Are there side effects?

No human safety trials have been published, so the side-effect profile in people is unknown. The animal studies reported no adverse effects at the tested doses, but that does not establish safety in humans, pregnancy or children (PMC 7843830).

Sources

Tier 1 (Ayush/CCRAS, pharmacopoeial, peer-reviewed journals):

• Renganathan R, Pillai SS. "Effect of Dhanwantharam Kashayam on Streptozotocin Induced Diabetic Wistar Rats." J Diabetes Metab Disord. 2020;19:1413–1419. PMID: 33553031 — PMC · PMC7843830
• Reghu S et al. "A synthetic formulation, Dhanwantharam kashaya, delays senescence in stem cells." Stem Cell Res Ther (PMC). 2019 — PMC · PMC6495558
• Nandakumar K et al. "Phytochemical evaluation of Dhanwantaram Kashayam." (pharmacognosy laboratory study) — bibliomed.org

Tier 2 (NHS/NCCIH — safety):

• "Ayurvedic Medicine: In Depth." National Center for Complementary and Integrative Health (NCCIH) — NCCIH

Tier 3 (classical aggregators, labeled as such):

• Dhanwantharam Kashayam — ingredients, classical references and traditional indications (classical Ayurvedic reference aggregator) — thepharmacylife.com

Disclaimer

This article is for educational purposes only and is not medical advice. Consult a qualified practitioner before using any Ayurvedic formulation. This is especially important if you are pregnant, breastfeeding, managing a medical condition (including diabetes), or taking prescription medicines.